These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 38741193)

  • 21. Associations Between APOE Variants, Tau and α-Synuclein.
    Rodriguez-Vieitez E; Nielsen HM
    Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
    Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
    Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    Kruse N; Schlossmacher MG; Schulz-Schaeffer WJ; Vanmechelen E; Vanderstichele H; El-Agnaf OM; Mollenhauer B
    PLoS One; 2016; 11(4):e0153564. PubMed ID: 27116005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.
    Choi ML; Gandhi S
    FEBS J; 2018 Oct; 285(19):3631-3644. PubMed ID: 29924502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
    Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
    PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naringenin-Functionalized Gold Nanoparticles and Their Role in α-Synuclein Stabilization.
    Maity A; Mondal A; Kundu S; Shome G; Misra R; Singh A; Pal U; Mandal AK; Bera K; Maiti NC
    Langmuir; 2023 May; 39(21):7231-7248. PubMed ID: 37094111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluid and tissue biomarkers in Parkinson's disease: Immunodetection or seed amplification? Central or peripheral?
    Painous C; Fernández M; Pérez J; de Mena L; Cámara A; Compta Y
    Parkinsonism Relat Disord; 2024 Apr; 121():105968. PubMed ID: 38168618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases.
    Pirhaghi M; Mamashli F; Moosavi-Movahedi F; Arghavani P; Amiri A; Davaeil B; Mohammad-Zaheri M; Mousavi-Jarrahi Z; Sharma D; Langel Ü; Otzen DE; Saboury AA
    Mol Pharm; 2024 May; 21(5):2097-2117. PubMed ID: 38440998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    Calderón-Garcidueñas L; Avila-Ramírez J; Calderón-Garcidueñas A; González-Heredia T; Acuña-Ayala H; Chao CK; Thompson C; Ruiz-Ramos R; Cortés-González V; Martínez-Martínez L; García-Pérez MA; Reis J; Mukherjee PS; Torres-Jardón R; Lachmann I
    J Alzheimers Dis; 2016 Sep; 54(2):597-613. PubMed ID: 27567860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Therapeutics for the Treatment of Alzheimer's and Parkinson's Disease.
    Singh K; Yadav D; Chauhan PS; Mishra M; Jin JO
    Curr Pharm Des; 2020; 26(7):755-763. PubMed ID: 31914906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases.
    Seino Y; Nakamura T; Kawarabayashi T; Hirohata M; Narita S; Wakasaya Y; Kaito K; Ueda T; Harigaya Y; Shoji M
    J Alzheimers Dis; 2019; 68(1):395-404. PubMed ID: 30814356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.
    Li X; James S; Lei P
    J Mol Neurosci; 2016 Nov; 60(3):298-304. PubMed ID: 27629562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson disease: PD biomarkers-use of α-synuclein reaches new levels.
    Montine TJ
    Nat Rev Neurol; 2011 May; 7(6):308-9. PubMed ID: 21556033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
    Braak H; Del Tredici K
    Cold Spring Harb Perspect Biol; 2016 Nov; 8(11):. PubMed ID: 27580631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine against Alzheimer's and Parkinson's Disease.
    Tandon A; Singh SJ; Chaturvedi RK
    Curr Pharm Des; 2021; 27(12):1507-1545. PubMed ID: 33087025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapeutic Approaches for the Treatment of Neurodegenerative Diseases: Challenges and Outcomes.
    Sushma ; Mondal AC
    CNS Neurol Disord Drug Targets; 2023; 22(3):404-416. PubMed ID: 34963438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
    Compta Y; Revesz T
    J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
    de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.